SEC Info - Syros Pharmaceuticals, Inc. - ‘S-8’ on 3/27/24

SEC Info℠

Home

My Interests

Help

Please Sign In

Syros Pharmaceuticals, Inc. – ‘S-8’ on 3/27/24 – ‘EX-23.2’

On: Wednesday, 3/27/24, at 7:04am ET · Effective: 3/27/24 · Accession #: 1193125-24-78195 · File #: 333-278250

Previous ‘S-8’: ‘S-8’ on 3/2/23 · Latest ‘S-8’: This Filing · 11 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/24  Syros Pharmaceuticals, Inc.       S-8         3/27/24    4:65K                                    Donnelley … Solutions/FA

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     33K 
                Employee Benefit Plan                                            
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML      9K 
 3: EX-23.2     Consent of Expert or Counsel                        HTML      5K 
 4: EX-FILING FEES  Filing Fees                                     HTML     14K

‘EX-23.2’ — Consent of Expert or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2016 Employee Stock Purchase Plan of Syros Pharmaceuticals, Inc. of our report dated March 27, 2024, with respect to the consolidated financial statements of Syros Pharmaceuticals, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2023, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Boston, Massachusetts

March 27, 2024

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed on / Effective on:	3/27/24	10-K
	12/31/23	10-K
		List all Filings

11 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/02/23  Syros Pharmaceuticals, Inc.       S-8         3/02/23    4:68K                                    Donnelley … Solutions/FA
11/14/22  Syros Pharmaceuticals, Inc.       10-Q        9/30/22   89:13M                                    Donnelley … Solutions/FA
 3/15/22  Syros Pharmaceuticals, Inc.       S-8         3/15/22    4:110K                                   Donnelley … Solutions/FA
 8/05/21  Syros Pharmaceuticals, Inc.       10-Q        6/30/21   78:10M                                    ActiveDisclosure/FA
 3/04/21  Syros Pharmaceuticals, Inc.       S-8         3/04/21    3:79K                                    Donnelley … Solutions/FA
 3/05/20  Syros Pharmaceuticals, Inc.       S-8         3/05/20    3:63K                                    Donnelley … Solutions/FA
 3/07/19  Syros Pharmaceuticals, Inc.       S-8         3/07/19    3:53K                                    Donnelley … Solutions/FA
 3/12/18  Syros Pharmaceuticals, Inc.       S-8         3/12/18    3:97K                                    Toppan Merrill/FA
 3/20/17  Syros Pharmaceuticals, Inc.       S-8         3/20/17    3:346K                                   Toppan Merrill Bridge/FA
 6/30/16  Syros Pharmaceuticals, Inc.       S-8         6/30/16    4:200K                                   Toppan Merrill/FA
 6/03/16  Syros Pharmaceuticals, Inc.       S-1                   28:10M                                    Toppan Merrill-FA

↑Top

Filing Submission 0001193125-24-078195 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)